Target intelligence / Profile preview

Promotion of Angiogenesis via Secretion of Growth Factors

Molecular classification
Growth factors, Secreted proteins, Signaling molecules
01

Overview

The promotion of angiogenesis via secretion of growth factors is a complex biological process where cells release specific proteins (angiogenic growth factors) that stimulate the formation of new blood vessels from pre-existing vasculature. This process is crucial in physiological processes and plays a significant role in various pathological conditions. Key growth factors include VEGF family members, FGF family members, PDGF, Angiopoietins, and TGF-β. These factors bind to their respective receptors on endothelial cells, triggering signaling cascades that promote endothelial cell proliferation, migration, survival, and differentiation, leading to new blood vessel formation. Disruptions in the balance of pro- and anti-angiogenic signals are implicated in many diseases characterized by abnormal vascularization.

Other names
Angiogenesis stimulationGrowth factor-induced angiogenesisNeovascularization via secreted factors
02

Mechanism of action

Growth factors bind to their respective receptors (e.g., VEGFRs, FGFRs, Tie2) on endothelial cells, initiating intracellular signaling cascades that promote endothelial cell proliferation, migration, survival, and differentiation, leading to new blood vessel formation. The net effect depends on the balance between pro- and anti-angiogenic signals.

03

Biological functions

AngiogenesisCell proliferationCell migrationExtracellular matrix remodelingWound healingTissue regenerationVessel maturationVessel stabilization
04

Disease associations

Cancer (tumor angiogenesis)Diabetic retinopathyChronic inflammationIschemic diseasesCardiovascular disease
05

Safety considerations

Excessive angiogenesis can promote tumor growth and metastasisInhibition of angiogenesis can impair wound healingVEGF inhibitors can cause hypertension, proteinuria, and thrombosisImpaired or dysregulated angiogenesis can cause complications with pregnancy
06

Interacting drugs

VEGF inhibitors (e.g., Bevacizumab, Sorafenib, Sunitinib)

3 more in the full profile.

07

Biomarkers

VEGF levels in serum/plasmaFGF levels in serum/plasmaAngiopoietin-1 and Angiopoietin-2 levelsCirculating endothelial cells (CECs)Circulating angiogenic factors

Beyond the preview

Go deeper on Promotion of Angiogenesis via Secretion of Growth Factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promotion of Angiogenesis via Secretion of Growth Factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call